PRS31 Modelling Survival of People with Cystic Fibrosis (PWCF) Aged ≥12 YEARS Homozygous for the F508DEL Mutation Treated with Ivacaftor/Tezacaftor/Elexacaftor and Ivacaftor (IVA/TEZ/ELX)

Saved in:
Bibliographic Details
Published inValue in health Vol. 24; p. S218
Main Authors Vega-Hernandez, G., MacGregor, G., Lopez, A., Daly, C., Rubin, J.L.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.06.2021
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2021.04.1095